Combination therapy with silibinin, pegylated interferon and ribavirin in a patient with hepatitis C virus genotype 3 reinfection after liver transplantation: a case report

by Knapstein, Johanna, Wörns, Marcus A, Galle, Peter R, Zimmermann, Tim
Published 2014

Docetaxel as Salvage Therapy in Highly Pretreated and Drug Resistant Gastrointestinal Carcinomas

by Sprinzl, Martin F., Wytopil, Sonia M., Dahmen, Anja, Kanzler, Stephan, Galle, Peter R., Moehler, Markus
Published 2008

Gemcitabine in combination with EGF-Receptor antibody (Cetuximab) as a treatment of cholangiocarcinoma: a case report

by Sprinzl, Martin F, Schimanski, Carl C, Moehler, Markus, Schadmand-Fischer, Simin, Galle, Peter R, Kanzler, Stephan
Published 2006

New perspectives on the renal slit diaphragm protein podocin

by Relle, Manfred, Cash, Hannes, Brochhausen, Christoph, Strand, Dennis, Menke, Julia, Galle, Peter R, Schwarting, Andreas
Published 2011

CellLineNavigator: a workbench for cancer cell line analysis

by Krupp, Markus, Itzel, Timo, Maass, Thorsten, Hildebrandt, Andreas, Galle, Peter R., Teufel, Andreas
Published 2013

Influence of the oncolytic parvovirus H-1, CTLA-4 antibody tremelimumab and cytostatic drugs on the human immune system in a human in vitro model of colorectal cancer cells

by Heinrich, Bernd, Goepfert, Katrin, Delic, Maike, Galle, Peter R, Moehler, Markus
Published 2013

Activation of the human immune system by chemotherapeutic or targeted agents combined with the oncolytic parvovirus H-1

by Moehler, Markus, Sieben, Maike, Roth, Susanne, Springsguth, Franziska, Leuchs, Barbara, Zeidler, Maja, Dinsart, Christiane, Rommelaere, Jean, Galle, Peter R
Published 2011

Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction

by Schulze-Bergkamen, Henning, Fleischer, Binje, Schuchmann, Marcus, Weber, Achim, Weinmann, Arndt, Krammer, Peter H, Galle, Peter R
Published 2006

Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27

by Wirtz, Stefan, Tubbe, Ingrid, Galle, Peter R., Schild, Hans J., Birkenbach, Mark, Blumberg, Richard S., Neurath, Markus F.
Published 2006

Disclosure and Experienced Social Support are not Related to Anxiety or Depression in a German HIV Patient Cohort

by Kittner, Jens M., Brokamp, Felix, Thomaidis, Thomas, Schmidt, Reinhold E., Wiltink, Jörg, Galle, Peter R., Jäger, Burkard
Published 2014

The functional cancer map: A systems-level synopsis of genetic deregulation in cancer

by Krupp, Markus, Maass, Thorsten, Marquardt, Jens U, Staib, Frank, Bauer, Tobias, König, Rainer, Biesterfeld, Stefan, Galle, Peter R, Tresch, Achim, Teufel, Andreas
Published 2011

Treatment of Allergic Airway Inflammation and Hyperresponsiveness by Antisense-Induced Local Blockade of Gata-3 Expression

by Finotto, Susetta, De Sanctis, George T., Lehr, Hans A., Herz, Udo, Buerke, Michael, Schipp, Mechthild, Bartsch, Brigitte, Atreya, Raja, Schmitt, Edgar, Galle, Peter R., Renz, Harald, Neurath, Markus F.
Published 2001

p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs

by Müller, Martina, Wilder, Sylvia, Bannasch, Detlev, Israeli, David, Lehlbach, Katrin, Li-Weber, Min, Friedman, Scott L., Galle, Peter R., Stremmel, Wolfgang, Oren, Moshe, Krammer, Peter H.
Published 1998

Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma

by Gockel, Ines, Schimanski, Carl C, Heinrich, Christian, Wehler, T, Frerichs, K, Drescher, Daniel, von Langsdorff, Christian, Domeyer, Mario, Biesterfeld, Stefan, Galle, Peter R, Junginger, Theodor, Moehler, Markus
Published 2006

Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer

by Teufel, Andreas, Steinmann, Silke, Siebler, Jürgen, Zanke, Christiane, Hohl, Herbert, Adami, Bernd, Schroeder, M, Klein, O, Höhler, Thomas, Galle, Peter R, Heike, Michael, Moehler, Markus
Published 2004

Genetic signatures shared in embryonic liver development and liver cancer define prognostically relevant subgroups in HCC

by Becker, Diana, Sfakianakis, Ioannis, Krupp, Markus, Staib, Frank, Gerhold-Ay, Aslihan, Victor, Anja, Binder, Harald, Blettner, Maria, Maass, Thorsten, Thorgeirsson, Snorri, Galle, Peter R, Teufel, Andreas
Published 2012

Single-agent therapy with sorafenib or 5-FU is equally effective in human colorectal cancer xenograft—no benefit of combination therapy

by Wehler, Thomas C., Hamdi, Swaantje, Maderer, Annett, Graf, Claudine, Gockel, Ines, Schmidtmann, Irene, Hainz, Michael, Berger, Martin R., Theobald, Matthias, Galle, Peter R., Moehler, Markus, Schimanski, Carl C.
Published 2012

Cetuximab-induced skin exanthema: prophylactic and reactive skin therapy are equally effective

by Wehler, Thomas C., Graf, Claudine, Möhler, Markus, Herzog, Jutta, Berger, Martin R., Gockel, Ines, Lang, Hauke, Theobald, Matthias, Galle, Peter R., Schimanski, Carl C.
Published 2013

Erratum to: Cetuximab-induced skin exanthema: prophylactic and reactive skin therapy are equally effective

by Wehler, Thomas C., Graf, Claudine, Möhler, Markus, Herzog, Jutta, Berger, Martin R., Gockel, Ines, Lang, Hauke, Theobald, Matthias, Galle, Peter R., Schimanski, Carl C.
Published 2013

Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma

by Weinmann, Arndt, Alt, Yvonne, Koch, Sandra, Nelles, Carina, Düber, Christoph, Lang, Hauke, Otto, Gerd, Zimmermann, Tim, Marquardt, Jens U, Galle, Peter R, Wörns, Marcus A, Schattenberg, Jörn M
Published 2015